Armen takes minority stake in Sign Capital Companions

0
25


European GP-stakes investor Armen has acquired a minority stake in asset administration agency Sign Capital Companions.

The transaction marks the fourth funding by Armen GP Stakes Fund I, and the agency’s second deal within the non-public credit score house.

Proceeds from the funding will probably be re-invested by Sign Capital’s senior administration into the agency’s funds, together with the third classic of its particular conditions fund which is at present fundraising and has already begun to deploy capital.

Learn extra: Rise in GP stake gross sales as buyers faucet into options

Sign Capital’s technique, administration and funding course of will stay unchanged following this transaction and the founding companions retain majority possession of the enterprise.

Sign Capital was based in 2015 and is concentrated on non-public credit score options for European company and actual property mid-market property.

The three co-founders have labored collectively for greater than 20 years, constructing a staff of 40 professionals with expertise in sourcing and executing advanced bilateral transactions throughout Europe.

The agency has €3.5bn (£2.9bn) of property beneath administration throughout its flagship particular scenario funds and different methods.

Learn extra: Armen takes minority stake in Refrain Capital

“As Sign Capital heads into its tenth yr, we consider this partnership will help the continued success of our funding platform,” stated Elad Shraga, chief funding officer Sign Capital.

“Sign Capital has constructed a world-class non-public asset administration agency, delivering robust, sustainable returns to buyers throughout market situations,” stated Catherine Haumesser, managing director, Armen, head of UK.

Macfarlanes served as authorized advisers to Sign Capital. Kirkland & Ellis and FTI Consulting served as advisers to Armen.

Learn extra: Blackstone sees $30tn non-public credit score alternative



LEAVE A REPLY

Please enter your comment!
Please enter your name here